Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trial

Gilead pulls 2 cancer accelerated approvals as changing lymphoma landscape disrupts confirmatory trialaliuMon, 01/24/2022 - 11:34